The NLRP3 inflammasome as a target for sensorineural hearing loss

被引:9
|
作者
Gregory, Grace E. [1 ,2 ,3 ]
Munro, Kevin J. [4 ,5 ]
Couper, Kevin N. [2 ,3 ]
Pathmanaban, Omar N. [1 ,2 ,3 ,6 ]
Brough, David [1 ,2 ,3 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Neurosci,Manchester Acad Hlth Sci Ctr, Manchester, England
[2] Univ Manchester, Geoffrey Jefferson Brain Res Ctr, Manchester Acad Hlth Sci Ctr, Northern Care Alliance NHS Grp, Manchester, England
[3] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester, England
[4] Univ Manchester, Manchester Ctr Audiol & Deafness, Sch Hlth Sci, Manchester, England
[5] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, England
[6] Salford Royal Hosp NHS Fdn Trust, Manchester Ctr Clin Neurosci, Dept Neurosurg, Salford, England
基金
英国医学研究理事会;
关键词
Sensorineural hearing loss; Inflammation; Cochlea; NLRP3; inflammasome; Interleukin-1;
D O I
10.1016/j.clim.2023.109287
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sensorineural hearing loss is the most common type of hearing loss in adults and occurs due to damage of the inner ear caused by a range of factors including ageing, excessive noise, toxins, and cancer. Auto-inflammatory disease is also a cause of hearing loss and there is evidence that inflammation could contribute to hearing loss in other conditions. Within the inner ear there are resident macrophage cells that respond to insults and whose activation correlates with damage. The NLRP3 inflammasome is a multi-molecular pro-inflammatory protein complex that forms in activated macrophages and may contribute to hearing loss. The aim of this article is to discuss the evidence for the NLRP3 inflammasome and associated cytokines as potential therapeutic targets for sensorineural hearing loss in conditions ranging from auto-inflammatory disease to tumour-induced hearing loss in vestibular schwannoma.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy
    Parsamanesh, Negin
    Moossavi, Maryam
    Bahrami, Afsane
    Fereidouni, Mohammad
    Barreto, George
    Sahebkar, Amirhossein
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 73 : 146 - 155
  • [42] NLRP3 inflammasome as a novel target for treatment-resistant epilepsy
    Edye, M. E.
    Brough, D.
    Allan, S. M.
    IMMUNOLOGY, 2014, 143 : 153 - 153
  • [43] NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease
    Zhuang, Dian
    Misra, Stuti L.
    Mugisho, Odunayo O.
    Rupenthal, Ilva D.
    Craig, Jennifer P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [44] Metabolic Syndrome: Is Nlrp3 Inflammasome a Trigger or a Target of Insulin Resistance?
    Mori, Marcelo A.
    Bezy, Olivier
    Kahn, C. Ronald
    CIRCULATION RESEARCH, 2011, 108 (10) : 1160 - 1162
  • [45] NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease
    Zhang, Yun
    Dong, Zhifang
    Song, Weihong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [46] The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target
    Somayeh Vafaei
    Hamed Taheri
    Yasamin Hajimomeni
    Amirhossein Fakhre Yaseri
    Firoozeh Abolhasani Zadeh
    Clinical and Translational Oncology, 2022, 24 : 1881 - 1889
  • [47] NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
    Yun Zhang
    Zhifang Dong
    Weihong Song
    Signal Transduction and Targeted Therapy, 5
  • [48] The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target
    Vafaei, Somayeh
    Taheri, Hamed
    Hajimomeni, Yasamin
    Yaseri, Amirhossein Fakhre
    Zadeh, Firoozeh Abolhasani
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (10): : 1881 - 1889
  • [49] Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
    Feng, Ya-Shuo
    Tan, Zi-Xuan
    Wang, Man-Man
    Xing, Ying
    Dong, Fang
    Zhang, Feng
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [50] The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout
    Szekanecz, Zoltan
    Szamosi, Szilvia
    Kovacs, Gergo E.
    Kocsis, Elek
    Benko, Szilvia
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2019, 670 : 82 - 93